SCHEDULE: Catheter Precision Sees 9.6% Stake by Jonathan Juchno

Jonathan Juchno and affiliated entities disclose a combined 9.6% beneficial ownership stake in Catheter Precision, Inc. common stock.

Summary

• Jonathan Juchno, an individual reporting person, holds beneficial ownership of 205,591 shares of Catheter Precision, Inc. common stock, representing 9.6% of the class.
• Thomas Walsh, another individual reporting person, holds beneficial ownership of 137,061 shares, representing 6.4% of the class.
• C/M Capital Partners, LP, an investment manager, beneficially owns 137,061 shares, or 6.4% of the class.
• C/M Capital Master Fund, LP beneficially owns 82,237 shares, representing 3.9% of the class.
• WVP Emerging Manager Onshore Fund LLC beneficially owns 54,824 shares, representing 2.6% of the class.
• Mercer Street Global Opportunity Fund, LLC beneficially owns 68,530 shares, representing 3.2% of the class.
• Mercer Street Capital Partners, LLC beneficially owns 68,530 shares, representing 3.2% of the class.
• The percentages are calculated based on an aggregate of 2,131,563 shares of Common Stock outstanding, which includes 1,738,955 shares outstanding as of February 6, 2026, and an additional 392,608 shares issued in a private placement.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive development, as significant beneficial ownership by an individual and affiliated funds can signal confidence in the company's long-term prospects, although the intent is passive.

Positives

• Increased institutional interest and a significant beneficial ownership stake by an individual and affiliated funds may signal confidence in Catheter Precision, Inc.'s long-term prospects.
• The disclosure of a 9.6% stake by Jonathan Juchno and related entities indicates a notable level of investor commitment.

Future Outlook

This filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance from the issuer.

Industry Context

StockSavvy.ai notes that a Schedule 13G filing indicates a passive investment by an individual or group, signaling increased institutional interest in Catheter Precision, a medical device company. This type of filing is common for investors accumulating a significant, but non-controlling, stake, suggesting a belief in the company's underlying value without seeking to influence management or control.

Stakeholder Impact

• Shareholders may perceive the increased institutional ownership as a positive signal of investor confidence in the company's future.

Key Dates

Recommendation

The disclosure of a significant, passive 9.6% stake by Jonathan Juchno and affiliated investment entities suggests a vote of confidence in Catheter Precision, Inc. However, without further information on the company's operational performance or strategic direction, this filing alone primarily indicates increased institutional interest rather than a catalyst for immediate strong action. A 'hold' recommendation reflects acknowledgment of this positive investor attention while awaiting more comprehensive financial or strategic updates.

Keywords

Catheter Precision, Jonathan Juchno, Thomas Walsh, C/M Capital, Mercer Street Capital, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investment, Medical Devices